Skip to main content

Want a detailed portfolio tracker?

Xenetic Biosciences (XBIO) P/E (2014 - 2026)

Xenetic Biosciences (XBIO) P/E from Apr 17, 2014 to Jul 21, 2026. The TTM Xenetic Biosciences (XBIO) P/E is -2.19. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Xenetic Biosciences (XBIO)

YearP/EChange
2026-2.19+63.12%
2025-1.34-13.48%
2024-1.55+31.42%
2023-1.18+106.24%
2022-0.57-76.95%
2021-2.49+104.27%
2020-1.22+84.30%
2019-0.66-99.64%
2018-184.53+775.95%
2017-21.07-55.37%
2016-47.20-76.15%
2015-197.89+150.44%
2014-79.01N/A

Comparison Xenetic Biosciences (XBIO) P/E with competitors

Xenetic Biosciences (XBIO) P/E is -2.19.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.08%
NBYStablecoin Development Corp0.00-100.20%
ENLVEnlivex Ltd0.07-103.41%
FGENFibroGen Inc0.24-110.95%
CHRSCoherus Biosciences Inc0.85-138.71%
FBIOFortress Biotech Inc0.95-143.30%
ORMPOramed Pharmaceuticals Inc1.50-168.57%
AGENAgenus Inc3.01-237.30%
INVAInnoviva Inc3.15-243.89%
VXRTVaxart Inc3.55-261.95%
CRMDCorMedix Inc3.63-265.54%
CVACCureVac N.V.4.45-302.82%
GLPGGalapagos NV4.86-321.67%
SRPTSarepta Therapeutics Inc4.88-322.73%
ABEOAbeona Therapeutics Inc5.39-345.79%
ABUSArbutus Biopharma Corp5.60-355.28%
ZVRAZevra Therapeutics Inc5.89-368.59%
SPROSpero Therapeutics Inc6.23-384.15%
CGENCompugen Ltd6.31-388.06%
RIGLRigel Pharmaceuticals6.87-413.52%
SLXNSilexion Therapeutics Corp7.30-432.86%
OMEROmeros Corporation9.26-522.40%
AUPHAurinia Pharmaceuticals Inc9.58-537.29%
PLXProtalix BioTherapeutics Inc10.89-596.87%
ACADAcadia Pharmaceuticals Inc11.73-635.08%
TBPHTheravance Biopharma Inc12.26-659.43%
ADMAAdma Biologics Inc12.42-666.54%
HRMYHarmony Biosciences Holdings Inc13.82-730.51%
SABSSAB Biotherapeutics Inc14.14-744.92%
NAGENiagen Bioscience Inc14.82-776.04%
INCYIncyte Corp15.82-821.86%
REGNRegeneron Pharmaceuticals Inc15.86-823.42%
PBYIPuma Biotechnology Inc17.32-889.98%
CPRXCatalyst Pharmaceuticals Inc17.44-895.62%
EXELExelixis Inc17.54-900.12%
TGTXTG Therapeutics Inc18.97-965.27%
MDXGMimedx Group Inc20.55-1037.65%
XOMAXOMA Royalty Corp22.87-1143.62%
ARGXArgen X SE24.30-1208.56%
CTMXCytomX Therapeutics Inc24.82-1232.42%
XOMAOXOMA Royalty Corp25.34-1256.32%
HALOHalozyme Therapeutics Inc25.62-1269.04%
XOMAPXOMA Royalty Corp25.67-1271.16%
VRTXVertex Pharmaceuticals Inc27.99-1377.22%
RPRXRoyalty Pharma plc - Class A28.69-1408.82%
SLNOSoleno Therapeutics Inc29.02-1423.78%
ASNDAscendis Pharma A/S30.09-1472.61%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1829.68%
APLSApellis Pharmaceuticals Inc39.02-1880.28%
BMRNBiomarin Pharmaceutical Inc42.21-2025.85%
KRYSKrystal Biotech Inc45.34-2168.72%
ONCBeiGene Ltd69.54-3272.67%
PHARPharming Group N.V.75.03-3522.93%
TECHBio-Techne Corp101.96-4751.69%
VCELVericel Corp109.92-5114.99%
ALNYAlnylam Pharmaceuticals Inc117.96-5481.98%
GMABGenmab140.29-6500.55%
TLXTelix Pharmaceuticals Ltd162.15-7497.97%
CORTCorcept Therapeutics Inc212.86-9811.30%